Chimeric Therapeutics Revenue

Chimeric Therapeutics had revenue of 5.55M AUD in the half year ending December 31, 2024, with 84.53% growth. This brings the company's revenue in the last twelve months to 2.04M, down -83.63% year-over-year. In the fiscal year ending June 30, 2024, Chimeric Therapeutics had annual revenue of 7.46M with 65.52% growth.

Revenue (ttm)

2.04M AUD

Revenue Growth

-83.63%

P/S Ratio

4.15

Revenue / Employee

n/a

Employees

n/a

Market Cap

5.25M USD

Revenue Chart

* This company reports financials in AUD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	7.46M	2.95M	65.52%
Jun 30, 2023	4.51M	1.89M	72.16%
Jun 30, 2022	2.62M	-	-
Jun 30, 2021	-	-	-
Jun 30, 2020	-	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Endo Inc.	1.73B
Veradigm	588.02M
Elite Pharmaceuticals	70.00M
Tian'an Technology Group	1.78M
Glass House Brands	215.62M
Northwest Biotherapeutics	1.47M
American Oncology Network	1.76B
Silence Therapeutics	27.70M

Revenue Rankings